{"id":"NCT00286494","sponsor":"Takeda","briefTitle":"Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Pioglitazone in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2007-08","completion":"2007-08","firstPosted":"2006-02-03","resultsPosted":"2011-09-27","lastUpdate":"2012-02-03"},"enrollment":493,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Alogliptin and pioglitazone","otherNames":["SYR110322","Alogliptin","AD-4833","Pioglitazone","Actos","SYR-322"]},{"type":"DRUG","name":"Alogliptin and pioglitazone","otherNames":["SYR110322","Alogliptin","AD-4833","Pioglitazone","Actos","SYR-322"]},{"type":"DRUG","name":"Pioglitazone","otherNames":["AD-4833","Actos"]}],"arms":[{"label":"Placebo","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 12.5 mg QD","type":"EXPERIMENTAL"},{"label":"Alogliptin 25 mg QD","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), combined with pioglitazone in adults with type 2 diabetes mellitus","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26.","timeFrame":"Baseline and Week 26.","effectByArm":[{"arm":"Placebo","deltaMin":-0.19,"sd":0.081},{"arm":"Alogliptin 12.5 mg QD","deltaMin":-0.66,"sd":0.056},{"arm":"Alogliptin 25 mg QD","deltaMin":-0.8,"sd":0.056}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":16,"exclusionCount":14},"locations":{"siteCount":77,"countries":["United States","Argentina","Australia","Brazil","Czechia","Germany","Guatemala","Hungary","India","Mexico","Netherlands","New Zealand","Peru","South Africa"]},"refs":{"pmids":["19650752","19793357"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":97},"commonTop":["Oedema peripheral","Nasopharyngitis","Upper respiratory tract infection","Headache","Influenza"]}}